The new Schedule M will be implemented from 1 January, 2026, to help MSMEs adjust to updated manufacturing standards.

The Indian government wants micro, small, and medium drugmakers to meet WHO GMP standards by the end of 2025 or face shutdown ...

In a groundbreaking advancement toward cell therapy and regenerative medicine, the Abu Dhabi Stem Cells Center (ADSCC) has ...

Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority ...

Telangana: Gland Pharma has received Establishment Inspection Report (EIR) from the United States Food and Drug ...

The Abu Dhabi Stem Cells Center (ADSCC) in the UAE has developed clinical-grade induced pluripotent stem cells (iPSCs) that ...